Impact of dysbiosis on the development of age-related inflammation
Impact of dysbiosis on the development of age-related inflammation
批准号:
10331167
负责人:
VISHWA DEEP DIXIT
金额:
$7.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-30 至 2025-04-30
关键词:
Adipose tissueAgeAgingAnti-Inflammatory AgentsAutoimmunityBacterial TranslocationChronicChronic DiseaseComplexDevelopmentDiseaseEnterococcus gallinarumEvolutionExhibitsFatty acid glycerol estersGenetic Predisposition to DiseaseImmuneImmune systemImmunityImpairmentIndividualInflammagingInflammationIntestinesLiverLymphoidMediatingMetabolic dysfunctionModernizationMusOrganPathologicProcessSocial ConditionsVisceralcommensal bacteriadysbiosisexperimental studygut bacteriagut microbesgut microbiotainsightintestinal barriernew therapeutic targetnovel therapeutic interventionopportunistic pathogenregenerativetertiary lymphoid organ
中文摘要
项目总结
数千年来,肠道微生物群和宿主免疫系统一直是共同进化的。然而,现代的
社会条件扰乱了这种共同进化,与免疫介导的疾病急剧上升不谋而合。
细菌跨过肠道屏障进入肠道外器官,如内脏脂肪
组织可能会产生严重的病理后果。我们最近发现,衰老与
内脏中第三级淋巴结构的形成,称为脂肪相关淋巴团(FALCs)
脂肪组织。随着年龄的增长,抗炎肠道细菌的丰度呈平行下降趋势。
机会性病原体增多,最终导致肠道免疫和屏障功能紊乱。
在最近的两项研究中,肠道共生菌鸡肠球菌被发现有很高的易位
药效,有能力转移到肝脏,并诱导遗传易感小鼠的自身免疫。在……里面
我们的初步实验发现,两种不同的鸡肠杆菌菌株表现出不同的能力
易位,单个鸡肠杆菌株易位速度在小鼠之间有很大差异
在复杂肠道中感染鸡冠埃希氏菌的小鼠与感染鸡冠埃希氏菌的小鼠的比较
微生物群落。我们假设肠道微生物移位到内脏脂肪组织会导致
FALC的形成和与年龄相关的炎症导致代谢功能障碍。在此应用程序中,我们建议
目的:1)确定鸡肠杆菌易位和持续对衰老相关的Falc形成的影响
和炎症,以及2)阐明鸡冠埃希氏菌移位和诱导衰老的机制(S)。
相关的法尔克形成和炎症。这些研究将提供对基本的
共生细菌跨过肠道屏障并导致年龄相关的机制
发炎。因此,它们可能为延缓慢性衰老的新治疗策略提供潜在的靶点。
随着年龄的增长。
英文摘要
Project summary
The resident gut microbiota and the host immune system have co-evolved for millennia. However, modern
societal conditions have disturbed this co-evolution, coinciding with a steep rise in immune-mediated diseases.
Bacterial translocation across the intestinal barrier and into extraintestinal organs such as the visceral adipose
tissues can have major pathological consequences. We recently discovered that aging is associated with
formation of tertiary lymphoid structures, known as Fat-associated lymphoid clusters (FALCs), in the visceral
adipose tissue. As an individual ages, the abundance of anti-inflammatory gut bacteria decreases with a parallel
increase in opportunistic pathogens, ultimately leading to disruption of intestinal immunity and barrier function.
In two recent studies, the gut commensal species Enterococcus gallinarum was found to have high translocation
efficacy, with the ability to translocate to the liver and induce autoimmunity in genetically predisposed mice. In
our preliminary experiments, we found that two different strains of E. gallinarum exhibit distinct capacities for
translocation, and that rates of translocation for a single E. gallinarum strain vary dramatically between mice
mono-colonized with E. gallinarum versus mice colonized with E. gallinarum in the presence of a complex gut
microbial community. We hypothesize that translocation of gut microbes to visceral adipose tissue results in
FALC formation and age-related inflammation leading to metabolic dysfunction. In this application, we propose
to: 1) determine the effect of E. gallinarum translocation and persistence on aging-associated FALC formation
and inflammation, and 2) elucidate the mechanism(s) that enable E. gallinarum to translocate and induce aging-
associated FALC formation and inflammation. These studies will provide insight into the fundamental
mechanisms by which commensal bacteria translocate across the intestinal barrier and induce age-related
inflammation. Thus, they may illuminate potential targets for novel therapeutic strategies delay chronic aging
with age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Caloric restriction-driven immunometabolic checkpoints of inflammation
-
批准号:10457565
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
-
批准号:10675111
-
项目类别:
-
资助金额:$165.13万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Caloric restriction-driven immunometabolic checkpoints of inflammation
-
批准号:10656332
-
项目类别:
-
资助金额:$55.01万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Immunometabolic regulation of bone inflammaging
-
批准号:10430514
-
项目类别:
-
资助金额:$50.25万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Immunometabolic regulation of bone inflammaging
-
批准号:10641819
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Yale Murine-TMC on Immune Cell Senescence Derived Inflammation
-
批准号:10553032
-
项目类别:
-
资助金额:$166.49万
-
财政年份:2022
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of dysbiosis on the development of age-related inflammation
-
批准号:10396668
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2020
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of dysbiosis on the development of age-related inflammation
-
批准号:10667392
-
项目类别:
-
资助金额:$7.06万
-
财政年份:2020
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of dysbiosis on the development of age-related inflammation
-
批准号:10259710
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2020
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
-
批准号:10091969
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2017
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
-
批准号:9216426
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2017
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of FGF21 on healthspan and lifespan
-
批准号:9148504
-
项目类别:
-
资助金额:$205.42万
-
财政年份:2016
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of FGF21 on healthspan and lifespan
-
批准号:9901985
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2016
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Thymic adipogenesis and age-related thymic demise
-
批准号:8818658
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2014
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Thymic adipogenesis and age-related thymic demise
-
批准号:9171367
-
项目类别:
-
资助金额:$61.63万
-
财政年份:2014
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Thymic adipogenesis and age-related thymic demise
-
批准号:8960920
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2014
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of CR on inflammasome driven immune-metabolic interactions.
-
批准号:8575882
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2013
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Impact of CR on inflammasome driven immune-metabolic interactions.
-
批准号:8730078
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2013
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Inflammasomes and the mechanism of thymic demise in aging
-
批准号:8669901
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2013
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
Inflammasomes and the mechanism of thymic demise in aging
-
批准号:8852033
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2013
-
负责人:VISHWA DEEP DIXIT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: